EconPapers    
Economics at your fingertips  
 

Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions

Farasat Bokhari, Franco Mariuzzo and Anna Rita Bennato
Additional contact information
Franco Mariuzzo: Centre for Competition Policy and School of Economics, University of East Anglia
Anna Rita Bennato: Centre for Competition Policy, University of East Anglia and Loughborough University

No 2016-01v3, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) from Centre for Competition Policy, University of East Anglia, Norwich, UK.

Abstract: New drug introductions are a key to growth for pharmaceutical firms. However not all innovations are the same and they may have differential effects that vary by firm size. We use quarterly sales data on UK pharmaceuticals in a dynamic panel model to estimate the impact of product (new drugs) and marketing (additional pack varieties) innovations within a therapeutic class on a firm's business unit growth. We find that product innovations lead to substantial growth in both the short and long run, whereas a new pack variety only produces short-term effects. The strategies are substitutes but the marginal effects are larger for product innovations relative to additional packs, and the effects are larger for smaller business units. Nonetheless, pack introductions offer a viable short-term growth strategy, especially for small and medium sized businesses.

Keywords: Growth; Innovation; Size; Pharmaceuticals; Business unit (search for similar items in EconPapers)
JEL-codes: L25 L65 O31 O32 (search for similar items in EconPapers)
Date: 2019-10-01
New Economics Papers: this item is included in nep-bec, nep-com, nep-ent, nep-sbm and nep-tid
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://ueaeco.github.io/working-papers/papers/ccp/CCP-16-01v3.pdf main text (application/pdf)

Related works:
Journal Article: Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions (2021) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:uea:ueaccp:2016_01v3

Ordering information: This working paper can be ordered from
Juliette Hardman, Center for Competition Policy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK

Access Statistics for this paper

More papers in Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) from Centre for Competition Policy, University of East Anglia, Norwich, UK. Contact information at EDIRC.
Bibliographic data for series maintained by Juliette Hardmad ().

 
Page updated 2025-04-01
Handle: RePEc:uea:ueaccp:2016_01v3